Moderna wins patent lawsuit against BioNTech/Pfizer
Havas is claiming "record results" in its first year of trading as a separate entity but, in truth, net revenue inching ...
By Christy Santhosh (Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its ...
The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy ...
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...
Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...
Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens ...
Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous ...
A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of ...
Verizon Communications ( VZ -2.28%), Toronto-Dominion Bank ( TD -1.59%), and Pfizer ( PFE -1.91%) look like steals at their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results